161 related articles for article (PubMed ID: 10439526)
21. [Clinicopathological characteristics of propylthiouracil-induced antineutrophil cytoplasmic antibodies-positive vasculitis and their target antigens: a report of 4 cases and literature review].
Xu X; Zhao M; Zhang Y; Guo X; Wang H
Zhonghua Nei Ke Za Zhi; 2002 Jun; 41(6):404-7. PubMed ID: 12137604
[TBL] [Abstract][Full Text] [Related]
22. A Case of p-ANCA-Positive Propylthiouracil-Induced Pyoderma Gangrenosum.
Seo JW; Son HH; Choi JH; Lee SK
Ann Dermatol; 2010 Feb; 22(1):48-50. PubMed ID: 20548880
[TBL] [Abstract][Full Text] [Related]
23. Propylthiouracil (PTU)-induced vasculitis associated with antineutrophil antibody against myeloperoxidase (MPO-ANCA).
Nakamori Y; Tominaga T; Inoue Y; Shinohara K
Intern Med; 2003 Jun; 42(6):529-33. PubMed ID: 12857055
[TBL] [Abstract][Full Text] [Related]
24. Clinical features and outcomes in patient with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment in Siriraj Hospital.
Visavachaipan N; Ong-Ajyooth L; Chanchairujuira T; Parichatikanond P; Choensuchon B
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S139-46. PubMed ID: 20364568
[TBL] [Abstract][Full Text] [Related]
25. Serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease receiving anti-thyroid medication.
Ashizawa K; Eguchi K
Intern Med; 2003 Jun; 42(6):463-4. PubMed ID: 12857041
[No Abstract] [Full Text] [Related]
26. Propylthiouracil induced C-ANCA positive agranulocytosis complicating Graves' thyrotoxicosis in pregnancy.
Finucane FM; O'Connell J; Kinsley BT
Ir J Med Sci; 2008 Mar; 177(1):69-71. PubMed ID: 17611791
[TBL] [Abstract][Full Text] [Related]
27. [Relapsing polychondritis developing in a patient with Graves' disease: a possible association with propylthiouracil].
Ohya N; Suzuki Y; Ichikawa Y; Ito K
Nihon Rinsho Meneki Gakkai Kaishi; 1999 Feb; 22(1):30-6. PubMed ID: 11185689
[TBL] [Abstract][Full Text] [Related]
28. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves' disease treated with propylthiouracil.
Sato H; Hattori M; Fujieda M; Sugihara S; Inomata H; Hoshi M; Miyamoto S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4270-3. PubMed ID: 11095466
[TBL] [Abstract][Full Text] [Related]
29. Case of propylthiouracil-induced vasculitis associated with anti-neutrophil cytoplasmic antibody (ANCA); review of literature.
Kitahara T; Hiromura K; Maezawa A; Ono K; Narabara N; Yano S; Naruse T; Takenouchi K; Yasumoto Y
Clin Nephrol; 1997 May; 47(5):336-40. PubMed ID: 9181282
[TBL] [Abstract][Full Text] [Related]
30. A long-term follow-up of serum myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves disease treated with propylthiouracil.
Ishii R; Imaizumi M; Ide A; Sera N; Ueki I; Horie I; Ando T; Usa T; Ejima E; Ashizawa K; Eguchi K
Endocr J; 2010; 57(1):73-9. PubMed ID: 19851036
[TBL] [Abstract][Full Text] [Related]
31. [A pediatric case of myeloperoxidase-antineutrophil cytoplasmic (ANCA)-related crescentic glomerulonephritis associated with propylthiouracil treatment for Graves' disease].
Kawasaki Y; Suzuki J; Sike T; Isome M; Nozawa R; Suzuki S; Kume K; Suzuki H
Nihon Jinzo Gakkai Shi; 1998 Nov; 40(8):612-7. PubMed ID: 9893462
[TBL] [Abstract][Full Text] [Related]
32. Cerebral pachyleptomeningitis associated with MPO-ANCA induced by PTU therapy.
Abe T; Nogawa S; Tanahashi N; Shiraishi J; Ikeda E; Suzuki N
Intern Med; 2007; 46(5):247-50. PubMed ID: 17329921
[TBL] [Abstract][Full Text] [Related]
33. Pyoderma gangrenosum and ulcerative colitis in the tropics.
Alese OB; Irabor DO
Rev Soc Bras Med Trop; 2008; 41(6):664-7. PubMed ID: 19142449
[TBL] [Abstract][Full Text] [Related]
34. Propylthiouracil induced ANCA-associated vasculitis in a 14-year-old girl.
Schamp V; Verfaillie C; Bonroy C; Vande Walle J; Raes A; Dehoorne J
Acta Clin Belg; 2015 Apr; 70(2):127-9. PubMed ID: 25937486
[TBL] [Abstract][Full Text] [Related]
35. Postoperative pyoderma gangrenosum: a rare complication after appendectomy.
Faghihi G; Abtahi-Naeini B; Nikyar Z; Jamshidi K; Bahrami A
J Postgrad Med; 2015; 61(1):42-3. PubMed ID: 25511218
[TBL] [Abstract][Full Text] [Related]
36. Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the course of Graves' disease: report of three adult cases.
Tanemoto M; Miyakawa H; Hanai J; Yago M; Kitaoka M; Uchida S
Am J Kidney Dis; 1995 Nov; 26(5):774-80. PubMed ID: 7485130
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of serum anti-myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Graves' disease treated with propylthiouracil and thiamazole.
Wada N; Mukai M; Kohno M; Notoya A; Ito T; Yoshioka N
Endocr J; 2002 Jun; 49(3):329-34. PubMed ID: 12201217
[TBL] [Abstract][Full Text] [Related]
38. Clinical Characteristics and Outcomes of Propylthiouracil-Induced Antineutrophil Cytoplasmic Antibody-Associated Vasculitis in Patients with Graves' Disease: A Median 38-Month Retrospective Cohort Study from a Single Institution in China.
Yang J; Yao LP; Dong MJ; Xu Q; Zhang J; Weng WW; Chen F
Thyroid; 2017 Dec; 27(12):1469-1474. PubMed ID: 29088997
[TBL] [Abstract][Full Text] [Related]
39. Rare association of pyoderma gangrenosum and palmoplantar pustulosis: a case report and review of the previous works.
Ohtsuka M; Yamamoto T
J Dermatol; 2014 Aug; 41(8):732-5. PubMed ID: 24986043
[TBL] [Abstract][Full Text] [Related]
40. Pyoderma gangrenosum, erythema elevatum diutinum and IgA monoclonal gammopathy.
Wayte JA; Rogers S; Powell FC
Australas J Dermatol; 1995 Feb; 36(1):21-3. PubMed ID: 7763217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]